Nyxoah (NYXH) Reiterated at Buy by Stifel: €4.4MM 1Q26 Revenue Guided Jan 13, 2026 07:24AM
Nyxoah SA (NYXH) PT Lowered to $9 at Piper Sandler Nov 14, 2025 08:12AM
Nyxoah secures up to $77 million in financing for US commercialization Nov 14, 2025 02:28AM
Nyxoah secures up to $77 million in financing for US expansion Nov 13, 2025 04:37PM
Oppenheimer Reiterates Outperform Rating on Nyxoah SA (NYXH) Aug 19, 2025 06:02AM


Aug 19, 2025 05:03AM Stifel Reiterates Buy Rating on Nyxoah SA (NYXH)
Aug 11, 2025 09:13AM Nyxoah stock surges after FDA approves Genio system for sleep apnea
Aug 11, 2025 07:00AM Cantor Fitzgerald Reiterates Overweight Rating on Nyxoah SA (NYXH)
Jul 28, 2025 08:35AM Stifel Reiterates Buy Rating on Nyxoah SA (NYXH)
Jun 13, 2025 08:26AM Piper Sandler Highlights Top Medtech Picks and Catalyst-Rich Names
May 19, 2025 06:44AM Cantor Fitzgerald Reiterates Overweight Rating on Nyxoah SA (NYXH)
Apr 21, 2025 07:57AM Nyxoah SA (NYXH) PT Lowered to $14 at Stifel
Mar 31, 2025 06:32AM Oppenheimer Reiterates Outperform Rating on Nyxoah SA (NYXH)
Mar 28, 2025 07:35AM Stifel Reiterates Buy Rating on Nyxoah SA (NYXH)
Mar 17, 2025 07:38AM Cantor Fitzgerald newsletter says Elutia best, Anteris worst performer
Mar 14, 2025 09:00AM Nyxoah SA (NYXH) PT Lowered to $15 at Stifel
Mar 14, 2025 06:50AM H.C. Wainwright Reiterates Buy Rating on Nyxoah SA (NYXH)
Dec 23, 2024 09:58AM Piper Sandler on HGNS Devices Following Eli Lilly's Zepbound FDA Indication Approval
Nov 7, 2024 06:19AM Oppenheimer Reiterates Outperform Rating on Nyxoah SA (NYXH)
Oct 14, 2024 06:46AM Nyxoah SA (NYXH) PT Lowered to $17 at H.C. Wainwright
Sep 30, 2024 07:27AM H.C. Wainwright Reiterates Buy Rating on Nyxoah SA (NYXH)
Sep 30, 2024 06:04AM Stifel Reiterates Buy Rating on Nyxoah SA (NYXH)
Jul 2, 2024 06:39AM H.C. Wainwright Reiterates Buy Rating on Nyxoah SA (NYXH)